Sean Lee
Recent Articles
Drug Innovator Launches Pivotal Cancer Trial Breakthrough 01/03/2025
Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ) has the potential to generate hundreds of millions of dollars over the next decade with its drug candidates, an H.C. Wainwright & Co. analyst wrote in a January 2 research note.
Due to permission requirements, not all quotes are shown.
